explore -WSS

explore

author：explore 2025-09-27 09:54:39 - browse：4132

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Judge denies Trump's request for new trial in E. Jean Carroll case

entertainment

WSS

The stock market has soared this year, but will it last? Experts weigh in

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Just how powerful is the placebo effect?

The stock market has soared this year, but will it last? Experts weigh in

Abortion clinic in Cancun will cater to Americans

hotspot

explore

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Sanders wants to replace patents with prizes for drug inventions

23andMe had bad news about my health. I wish a person had delivered it

The Sacklers, horror, and ‘The Fall of the House of Usher’

Alkermes shareholders re

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

The cancer drug shortage isn’t new — and neither are the solutions

10 million people disenrolled from Medicaid over past six months

New air purifier tech could be key to improving indoor air quality

Abortion clinic in Cancun will cater to Americans

entertainment

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Stanford president’s abrupt resignation sparks debate

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Diversify hospital leadership teams to protect BIPOC patient health

Mystery swirls around US soldier who entered North Korea days ago, officials say

MoonLake credibility takes another hit with mid

knowledge

entertainment

focus

hotspot